Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPageGroup Regulatory News (PAGE)

Share Price Information for PageGroup (PAGE)

Share Price is delayed by 15 minutes
Get Live Data
111.20    -6.70 (-5.68%)
Bid:
114.30
Ask:
114.70
Spread: 0.40 (0.35%)
Market Cap: £346.24m
PAGE Live PriceLast checked at - London Stock Exchange

Intraday PageGroup Share Chart

EPT Disclosure

4 Sep 2008 11:12

RNS Number : 7320C
Credit Suisse Securities (Eur) Ltd
04 September 2008
 

FORM 38.5 (b)

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 

WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS

BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(b) of the Takeover Code)

1. KEY INFORMATION 

Name of exempt principal trader

Credit Suisse Securities (Europe) Limited

 

Company dealt in

Michael Page International Plc

 

Class of relevant security to which the dealings being disclosed relate (Note 1)

 

Ordinary Shares

Date of dealing

03-Sep-2008

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2) 

 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

 

 

71312

0.022

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell 

 

 

 

 

Total

 

 

71312

0.022

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2) 

Class Of Relevant Security : 

Long

Short

(1) Relevant Securities 

 

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchasesell 

 

 

Total

 

 

(c) Rights to subscribe (Note 2) 

Class of relevant security:

Details

 

 

3. DEALINGS (Note 3)

(a) Purchases and sales 

Purchase/sale

Number of securities

Price per unit (Note 4)

Buy

5251

3.535 (GBP)

Buy

4316

3.4925 (GBP)

Buy

3624

3.5225 (GBP)

Buy

2602

3.5225 (GBP)

Buy

2602

3.5225 (GBP)

Buy

2358

3.5 (GBP)

Buy

2293

3.5225 (GBP)

Buy

2292

3.5225 (GBP)

Buy

2166

3.51 (GBP)

Buy

2117

3.5475 (GBP)

Buy

2068

3.5225 (GBP)

Buy

1885

3.52 (GBP)

Buy

1706

3.5325 (GBP)

Buy

1384

3.5475 (GBP)

Buy

1326

3.5275 (GBP)

Buy

1112

3.5 (GBP)

Buy

1085

3.5475 (GBP)

Buy

1083

3.5 (GBP)

Buy

1067

3.5375 (GBP)

Buy

1059

3.5 (GBP)

Buy

919

3.5 (GBP)

Buy

788

3.535 (GBP)

Buy

701

3.5 (GBP)

Buy

694

3.55 (GBP)

Buy

689

3.5025 (GBP)

Buy

684

3.495 (GBP)

Buy

674

3.5 (GBP)

Buy

560

3.5675 (GBP)

Buy

500

3.5375 (GBP)

Buy

441

3.5075 (GBP)

Buy

391

3.5 (GBP)

Buy

300

3.515 (GBP)

Buy

300

3.535 (GBP)

Buy

300

3.5675 (GBP)

Buy

219

3.5375 (GBP)

Buy

175

3.5 (GBP)

Buy

167

3.5025 (GBP)

Buy

154

3.5675 (GBP)

Sell

4003

3.5125 (GBP)

Sell

3972

3.4925 (GBP)

Sell

3200

3.4925 (GBP)

Sell

3022

3.4975 (GBP)

Sell

2583

3.505 (GBP)

Sell

2257

3.5275 (GBP)

Sell

1300

3.4975 (GBP)

Sell

1300

3.53 (GBP)

Sell

1201

3.52 (GBP)

Sell

1196

3.4925 (GBP)

Sell

1174

3.4975 (GBP)

Sell

1000

3.495 (GBP)

Sell

1000

3.495 (GBP)

Sell

964

3.4975 (GBP)

Sell

939

3.56 (GBP)

Sell

861

3.4975 (GBP)

Sell

711

3.515 (GBP)

Sell

660

3.535 (GBP)

Sell

593

3.4925 (GBP)

Sell

587

3.4975 (GBP)

Sell

566

3.53 (GBP)

Sell

519

3.495 (GBP)

Sell

500

3.5325 (GBP)

Sell

500

3.4975 (GBP)

Sell

500

3.5175 (GBP)

Sell

500

3.53 (GBP)

Sell

488

3.505 (GBP)

Sell

479

3.5125 (GBP)

Sell

342

3.5425 (GBP)

Sell

270

3.535 (GBP)

Sell

200

3.5325 (GBP)

Sell

174

3.5375 (GBP)

Sell

172

3.55 (GBP)

Sell

116

3.515 (GBP)

Sell

116

3.5325 (GBP)

Sell

96

3.5375 (GBP)

Sell

79

3.5125 (GBP)

Sell

68

3.4925 (GBP)

Total Buys: 52,052

Total Sells: 38,208

(b) Derivatives transactions (other than options) 

Product name, e.g. CFD

Long/short (Note 5)

Number of securities (Note 6)

Price per unit (Note 4)

 

 

 

 

(c) Options transactions in respect of existing securities 

(i) Writing, selling, purchasing or varying 

Product name,e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 6)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

 

 

 

 

 

 

 

(ii) Exercising 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 4)

 

 

 

(d) Other dealings (including new securities) (Note 3) 

Nature of transaction (Note 7)

Details

Price per unit (if applicable) (Note 4)

 

 

 

4. OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 38.5(b) attached? (Note 8)  No

Date of disclosure

 04-09-2008

 

Contact name

 Simon Crawley/ Carolyn Collins

 

Telephone number

 020 7888 5416

 

Name of offeree/offeror with which connected

Adecco

 

Nature of connection (Note 9)

ADVISOR

Notes 

The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMSSFFSLSASEFU
Date   Source Headline
3rd Mar 20217:00 amRNSFinal Results
2nd Mar 20219:00 amRNSHolding(s) in Company
1st Mar 202110:09 amRNSNotice of 2020 Full Year Results
17th Feb 20213:05 pmRNSDirector Declaration
13th Jan 20217:00 amRNSFOURTH QUARTER AND FULL YEAR 2020 TRADING UPDATE
8th Jan 202110:12 amRNSNotice of Q4 and FY 2020 Trading Update
24th Dec 202010:54 amRNSBoard changes
18th Dec 202010:52 amRNSDirector Declaration
8th Dec 20201:06 pmRNSResults of External Audit Tender
7th Dec 20205:35 pmRNSDirector Declaration
14th Oct 20207:00 amRNSThird Quarter Update and COVID-19 Strategy
9th Oct 20201:32 pmRNSNotice of Third Quarter 2020 Trading Update
1st Oct 202010:14 amRNSBlock listing Interim Review
22nd Sep 20209:07 amRNSDirector Declaration
2nd Sep 20209:03 amRNSHolding(s) in Company
17th Aug 20209:45 amRNSHolding(s) in Company
5th Aug 20207:00 amRNSHalf Year Results
9th Jul 20207:00 amRNSSECOND QUARTER, FIRST HALF AND COVID-19 UPDATE
8th Jul 20209:04 amRNSNotice of Second Quarter 2020 Trading Update
4th Jun 20203:36 pmRNSResult of AGM
12th May 202011:03 amRNSNotice of 2020 Q2 Results
7th May 202011:12 amRNSHolding(s) in Company
1st May 202010:30 amRNSChange in Director’s Details
27th Apr 202012:31 pmRNSAnnual Report and Annual General Meeting
8th Apr 20207:00 amRNSFIRST QUARTER AND COVID-19 UPDATE
1st Apr 20203:00 pmRNSTotal Voting Rights
1st Apr 20201:30 pmRNSBlock listing Interim Review
20th Mar 20204:43 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
20th Mar 202011:40 amRNSHolding(s) in Company
18th Mar 20202:24 pmRNSDirector/PDMR Shareholding
16th Mar 20201:12 pmRNSDirector/PDMR Shareholding
16th Mar 20201:09 pmRNSDirector/PDMR Shareholding
10th Mar 202011:59 amRNSHolding(s) in Company
5th Mar 20207:00 amRNSFinal Results
2nd Mar 20201:14 pmRNSTotal Voting Rights
28th Feb 202011:47 amRNSNotice of 2019 Full Year Results
14th Jan 20207:00 amRNSFOURTH QUARTER AND FULL YEAR 2019 TRADING UPDATE
9th Jan 20209:46 amRNSNotice of Q4 and Full Year 2019 Trading Update
2nd Jan 20209:00 amRNSTotal Voting Rights
20th Dec 20198:44 amRNSDirector Declaration
2nd Dec 20191:36 pmRNSTotal Voting Rights
22nd Nov 20191:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20191:04 pmRNSDirector/PDMR Shareholding
8th Oct 20197:00 amRNSTHIRD QUARTER 2019 TRADING UPDATE
2nd Oct 201911:06 amRNSBlock listing Interim Review
2nd Oct 201910:03 amRNSTotal Voting Rights
21st Aug 201910:01 amRNSHolding(s) in Company
16th Aug 20199:59 amRNSHolding(s) in Company
7th Aug 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.